In-vitro dissolution testing of 5-aminosalicylic acid release from pH dependent mesalazine formulations

被引：0
|
作者：
Kruis, Wolfgang [2 ]
Greinwald, Roland [1 ]
Fingerhut, Thomas [3 ]
机构：
[1] Dr Falk Pharma GmbH, Res & Dev, Freiburg, Germany
[2] Univ Cologne, Evangel Krankenhaus Kalk, Cologne, Germany
[3] Dr Falk Pharma GmbH, Qual Assurance & Qual Control, Freiburg, Germany
来源：
JOURNAL OF CROHNS & COLITIS | 2011年 / 5卷 / 05期
关键词：
ACTIVE ULCERATIVE-COLITIS; DOUBLE-BLIND; PELLETS; TABLETS; TRIAL;
D O I：
10.1016/j.crohns.2011.04.003
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：499 / 500
页数：2
相关论文
共 50 条
  • [1] In-vitro dissolution testing of 5-aminosalicylic acid release from pH dependent mesalazine formulations Reply
    Tenjarla, Srini
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (05): : 501 - 501
  • [2] Release of 5-aminosalicylic acid from mesalazine formulations: a novel dynamic dissolution model simulating gastrointestinal pH changes
    Demyanova, E.
    Vakhitov, T.
    Sitkin, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S406 - S406
  • [3] DELAYED-RELEASE MESALAZINE (5-AMINOSALICYLIC ACID) - COAT DISSOLUTION AND EXCRETION IN ILEOSTOMY SUBJECTS
    RILEY, SA
    TAVARES, IA
    BENNETT, A
    MANI, V
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 26 (02) : 173 - 177
  • [4] 5-aminosalicylic acid release from pH-Dependent, delayed-release formulations: The importance of consistent and steady release profiles
    Tenjarla, Srini
    Romasanta, Vallente
    Abinusawa, Adeyinka
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S434 - S434
  • [5] Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
    Adeyinka Abinusawa
    Srini Tenjarla
    Advances in Therapy, 2015, 32 : 477 - 484
  • [6] Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels
    Abinusawa, Adeyinka
    Tenjarla, Srini
    ADVANCES IN THERAPY, 2015, 32 (05) : 477 - 484
  • [7] Comparative disintegration and dissolution testing of three formulations of 5-aminosalicylic acid (5-ASA)
    Low, A
    Miller, RA
    GASTROENTEROLOGY, 1999, 116 (04) : A77 - A77
  • [8] Understanding 5-aminosalicylic acid (5-ASA) release profiles from pH-Dependent delayed-release formulations: a Multidisciplinary approach
    Tenjarla, Srini
    Karlstadt, Robyn
    Joseph, Raymond
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S435 - S435
  • [9] Mesalazine (5-aminosalicylic acid) induced chronic hepatitis
    Deltenre, P
    Berson, A
    Marcellin, P
    Degott, C
    Biour, M
    Pessayre, D
    GUT, 1999, 44 (06) : 886 - 888
  • [10] OATP-mediated uptake of mesalazine (5-aminosalicylic acid)
    Koenig, J.
    Glaeser, H.
    Keiser, M.
    Mandery, K.
    Klotz, U.
    Fromm, M. F.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 11 - 11
12345